Compositions Comprising Nicotinic Agonists and Methods of Using Same
AssigneeNeuroDerm, Ltd.
InventorEliahu Heldman
Life of this patent
Estimating the term…
Abstract
The disclosure is directed at least in part to compositions and methods comprising nicotinic agonists for treating e.g., nervous system disorders, in particular, to combination therapies that include a nicotinic agonist (for example, nicotine) and a nicotinic acetylcholine receptor desensitization inhibitor (for example, opipramol).
Claims24
1-3. (canceled)
A method of treating anxiety or depression, comprising co-administering to a patient in need thereof a therapeutically effective amount of nicotine, or a pharmaceutically acceptable salt or N-oxide thereof, and opipramol, or a pharmaceutically acceptable salt or ester thereof.
5-7. (canceled)
(canceled)
11-12. (canceled)
15-17. (canceled)
(canceled)
21-25. (canceled)
27-34. (canceled)
36-46. (canceled)
49-66. (canceled)
A method of treating anxiety, comprising co-administering to a patient in need thereof a therapeutically effective amount of nicotine, or a pharmaceutically acceptable salt or N-oxide thereof, and opipramol, or a pharmaceutically acceptable salt or ester thereof.
A method of treating depression, comprising co-administering to a patient in need thereof a therapeutically effective amount of nicotine, or a pharmaceutically acceptable salt or N-oxide thereof, and opipramol, or a pharmaceutically acceptable salt or ester thereof.
Dependencies are inferred from the claim text.